XML 55 R37.htm IDEA: XBRL DOCUMENT
v3.7.0.1

Business Segments (Tables) | 12 Months Ended
--- | ---
Jun. 30, 2017
Segment Reporting [Abstract] |
Schedule of information regarding reportable segments |
For the Years Ended June 30 |  |  | 2017 |  |  | 2016 |  |  | 2015 |
Net sales |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
MFAs and other |  |  |  | $ | 321,430 |  |  |  |  | $ | 339,916 |  |  |  |  | $ | 335,735 |  |
Nutritional Specialties |  |  |  |  | 111,282 |  |  |  |  |  | 94,084 |  |  |  |  |  | 81,702 |  |
Vaccines |  |  |  |  | 65,033 |  |  |  |  |  | 52,140 |  |  |  |  |  | 53,363 |  |
Animal Health |  |  |  |  | 497,745 |  |  |  |  |  | 486,140 |  |  |  |  |  | 470,800 |  |
Mineral Nutrition |  |  |  |  | 218,298 |  |  |  |  |  | 216,685 |  |  |  |  |  | 227,102 |  |
Performance Products |  |  |  |  | 48,238 |  |  |  |  |  | 48,701 |  |  |  |  |  | 50,689 |  |
Total segments |  |  |  | $ | 764,281 |  |  |  |  | $ | 751,526 |  |  |  |  | $ | 748,591 |  |
Depreciation and amortization |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Animal Health |  |  |  | $ | 20,132 |  |  |  |  | $ | 17,149 |  |  |  |  | $ | 15,430 |  |
Mineral Nutrition |  |  |  |  | 2,332 |  |  |  |  |  | 2,467 |  |  |  |  |  | 2,468 |  |
Performance Products |  |  |  |  | 939 |  |  |  |  |  | 807 |  |  |  |  |  | 577 |  |
Total segments |  |  |  | $ | 23,403 |  |  |  |  | $ | 20,423 |  |  |  |  | $ | 18,475 |  |
Adjusted EBITDA |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Animal Health |  |  |  | $ | 130,261 |  |  |  |  | $ | 127,442 |  |  |  |  | $ | 120,259 |  |
Mineral Nutrition |  |  |  |  | 17,426 |  |  |  |  |  | 14,971 |  |  |  |  |  | 14,429 |  |
Performance Products |  |  |  |  | 2,057 |  |  |  |  |  | 970 |  |  |  |  |  | 2,646 |  |
Total segments |  |  |  | $ | 149,744 |  |  |  |  | $ | 143,383 |  |  |  |  | $ | 137,334 |  |
Reconciliation of income before income taxes to Adjusted EBITDA |  |  |  |
Income before income taxes |  |  |  | $ | 80,543 |  |  |  |  | $ | 76,761 |  |  |  |  | $ | 78,763 |  |
Interest expense, net |  |  |  |  | 14,906 |  |  |  |  |  | 16,592 |  |  |  |  |  | 14,305 |  |
Depreciation and amortization–Total segments |  |  |  |  | 23,403 |  |  |  |  |  | 20,423 |  |  |  |  |  | 18,475 |  |
Depreciation and amortization–Corporate |  |  |  |  | 2,598 |  |  |  |  |  | 3,029 |  |  |  |  |  | 3,129 |  |
Corporate costs |  |  |  |  | 29,625 |  |  |  |  |  | 29,323 |  |  |  |  |  | 27,315 |  |
Acquisition-related cost of goods sold |  |  |  |  | — |  |  |  |  |  | 2,566 |  |  |  |  |  | — |  |
Acquisition-related accrued compensation |  |  |  |  | 1,680 |  |  |  |  |  | 1,680 |  |  |  |  |  | 747 |  |
Acquisition-related transaction costs |  |  |  |  | 1,274 |  |  |  |  |  | 618 |  |  |  |  |  | — |  |
Acquisition-related other, net |  |  |  |  | (972) |  |  |  |  |  | — |  |  |  |  |  | — |  |
Pension settlement cost |  |  |  |  | 1,702 |  |  |  |  |  | — |  |  |  |  |  | — |  |
Gain on insurance settlement |  |  |  |  | (7,500) |  |  |  |  |  | — |  |  |  |  |  | — |  |
Foreign currency (gains) losses, net |  |  |  |  | (113) |  |  |  |  |  | (7,609) |  |  |  |  |  | (5,400) |  |
Loss on extinguishment of debt |  |  |  |  | 2,598 |  |  |  |  |  | — |  |  |  |  |  | — |  |
Adjusted EBITDA–Total segments |  |  |  | $ | 149,744 |  |  |  |  | $ | 143,383 |  |  |  |  | $ | 137,334 |  |
As of June 30 |  |  | 2017 |  |  | 2016 |
Identifiable assets |  |  |  |  |  |  |  |  |  |  |  |  |
Animal Health |  |  |  | $ | 442,521 |  |  |  |  | $ | 444,751 |  |
Mineral Nutrition |  |  |  |  | 55,184 |  |  |  |  |  | 57,939 |  |
Performance Products |  |  |  |  | 23,681 |  |  |  |  |  | 21,557 |  |
Total segments |  |  |  |  | 521,386 |  |  |  |  |  | 524,247 |  |
Corporate |  |  |  |  | 102,011 |  |  |  |  |  | 83,588 |  |
Total |  |  |  | $ | 623,397 |  |  |  |  | $ | 607,835 |  |

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8906-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8813-108599 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8721-108599 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8736-108599 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration